Psychotherapy in schizophrenia: the end of the pioneers' period.
نویسنده
چکیده
A position in regard to evaluation of the efficacy of psychotherapy with schizophrenia is presented. It is suggested that personal motivation is essential in this type of treatment.
منابع مشابه
Rehabilitation of Schizophrenia: At the End or in the Beginning?
The Majority of the long stay psychiatric patients who are in need of rehabilitation suffer from schizophrenia. Most of them enter the old age with this illness, and besides the consequences of schizophrenia, they are facing the deprivation and misery due to the old age. In contrast to the previous decades in which there was no effective treatment for schizophrenia, today with the immediate dia...
متن کاملEffectiveness of group body psychotherapy for negative symptoms of schizophrenia: multicentre randomised controlled trial†
BACKGROUND Negative symptoms of schizophrenia have a severe impact on functional outcomes and treatment options are limited. Arts therapies are currently recommended but more evidence is required. AIMS To assess body psychotherapy as a treatment for negative symptoms compared with an active control (trial registration: ISRCTN84216587). METHOD Schizophrenia out-patients were randomised into ...
متن کاملEvaluation of the Pharmacotherapeutic Pattern for Treating Schizophrenia in Bangladesh
Background: Studies of the pharmacotherapeutic pattern on schizophrenic patients are few clinical therapy is one of the bases for the assessment of the treatment of Schizophrenia. Objectives: This study aimed to analyze the demographics of these patients along with current trends of drug prescribing practice in Bangladesh. Methods: This survey was conducted over 6 months at the National Insti...
متن کاملEvaluation of the efficacy and safety of pregabalin as an adjuvant to antipsychotics in patients with chronic schizophrenia: a six-week pilot double-blind placebo-controlled trial
Introduction and objectives: Antipsychotics or dopamine receptor antagonists are the major components of treatment but about 10-20% of patients with schizophrenia do not benefit from treatment with antidopaminergic agents, indicating other neuronal systems may be involved in this disorder (2). Dysregulation of both excitatory and inhibitory mechanisms N-Methyl-D-aspartic acid (NMDA) and γ-Amino...
متن کاملEffects of metformin on weight loss and metabolic control in obese patients with schizophrenia and schizoaffective disorder: a randomized, double-blind, controlled clinical trial
Abstract Objective: The effect of metformin on weight changes and some metabolic parameters in patients with schizophrenia and schizoaffective disorder was investigated in this study. Methods: This study, performed during 2018-2019, was a randomized, double-blind, controlled clinical trial. A total of 66 obese patients (BMI≥27) with schizophrenia and schizoaffective disorder, hospitalized in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Schizophrenia bulletin
دوره 10 4 شماره
صفحات -
تاریخ انتشار 1984